Skip to main content

Supplementary Table 1 Characteristics of patients in the study

From: Circulating cytotoxic CD8+ CD28- T cells in ankylosing spondylitis

 

Patient value

Normal range

Duration of AS since

9.9 ± 9.3

 

diagnosis (years)

  

Time since onset of

16.6 ± 12.2

 

symptoms (years)

  

ESR (mm/hour)

31.4 ± 20.3

<15

Leucocytes (G/I)

9.08 ± 1.92

3.8–10.5

Erythrocytes (T/I)

4.88 ± 0.59

3.9–5.7

Platelets (G/I)

344 ± 99

140–345

HAQ-S score (0–3)

0.89 ± 0.51

 

BASFI (0–10)

4.67 ± 2.05

 

BASMI (0–10)

5.04 ± 2.20

 
  1. AS, ankylosing spondylitis; BASFI, Bath Ankylosing Spondylitis Functional Index; BASMI, Bath Ankylosing Spondylitis Metrology Index; ESR, erythrocyte sedimentation rate; HAQ-S = Health Assessment Questionnaire; G/l, giga/liter; T/l, tara/liter.